Company intelligence / Profile preview

VoxelCloud

Los Angeles, California, United Statesvoxelcloud.ai ↗

Ownership: Private
Employees: ~35
Development stage: Other

Overview

VoxelCloud develops AI-powered medical image analysis platforms to assist clinicians with early detection and diagnosis of diseases such as lung cancer, diabetic retinopathy, coronary heart disease, and skin disorders. Its solutions are commercially available in China—some have received regulatory approval from the NMPA—and are used globally to improve diagnostic accuracy and workflow efficiency.

Therapeutic areas: DermatologyOphthalmologyCardiovascularOncology
Modalities: Device (AI-based diagnostic software)Non-pharmacological therapy (diagnostic support)Software as a Medical Device (SaMD)
Industry: Medical Imaging

Partnerships

Genentech (academic collaboration/grants)

Beyond the preview

Go deeper on VoxelCloud.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VoxelCloud.

Explore the full profile